PubMed · 2015 · 65 citations · 31 references
Open access
Life SciencesOncologyPharmacologyApoptosisCell SignalingSignal TransductionApoptosis ModulationApoptosis PharmacologyApoptosis RegulationApoptotic SignalingBcl-2 Family ProteinsProstate CancerActive Compound IsolationCell Cycle InhibitionCyclin RegulationStat3 SignalingSurvivin Inhibition
STAT3 has been recognized as an efficacious drug target for prostate cancer because of its constitutive activation in this fatal disease. We recently identified the root bark of Morus alba Linn. as a potential STAT3 inhibitor among 33 phytomedicines traditionally used in Korea. Morusin, an active compound isolated from the root bark of Morus alba, has shown anti-oxidant and anti-inflammatory effects. In the present study, we examined whether morusin has a potential as an anti-cancer agent in prostate cancer. We found that morusin suppressed viability of prostate cancer cells, but little effect in normal human prostate epithelial cells. Morusin also reduced STAT3 activity by inhibiting its phosphorylation, nuclear accumulation, and DNA binding activity. In addition, morusin down-regulated expression of STAT3 target genes encoding Bcl-xL, Bcl-2, Survivin, c-Myc and Cyclin D1, which are involved in regulation of apoptosis and cell cycle. Furthermore, morusin induced apoptosis in human prostate cancer cells by reducing STAT3 activity. Taken together, these results suggest that morusin could be a potentially therapeutic agent for prostate cancer by reducing STAT3 activity and inducing apoptosis.
31
Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text
Rebecca L. Siegel, Deepa Naishadham, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2013 · 11.9K citations · Full text
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2012
Kyu‐Won Jung, Young‐Joo Won, Hyun-Joo Kong et al. · Cancer Research and Treatment · 2015 · 1.2K citations · Full text
Cancer Statistics in Korea: Incidence, Mortality, Survival and Prevalence in 2010
Kyu‐Won Jung, Young‐Joo Won, Hyun-Joo Kong et al. · Cancer Research and Treatment · 2013 · 431 citations · Full text
Medicine, Oncology, Cancer Control +16